twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2010
vol. 112
 
Share:
Share:
abstract:
Case report

Ocular masquerade syndrome in a patient with chronic lymphocytic leukemia

Agnieszka Kubicka-Trząska
1
,
Monika Gedliczka
1
,
Bożena Romanowska-Dixon
1

  1. Z Kliniki Okulistyki i Onkologii Okulistycznej Katedry Okulistyki Uniwersytetu Jagiellońskiego Collegium Medicum w Krakowie
Online publish date: 2010/12/22
View full text Get citation
 
Purpose: To report a rare case of a masquerading syndrome in a course of chronic lymphocytic leukemia (CLL).

Material and methods: A 57 years old woman with bilateral lacrimal glands enlargement and chronic uveitis unresponsive to local steroids, was studied. Patient’s general history was positive for chronic lymphocytic leukemia, B cell (B-CLL); actually remission. The patient underwent complete ophthalmic examination with additional A and B-scan ultrasonography (USG), computed

tomography (CT) and nuclear magnetic resonance (NMR) imaging of orbital cavities and also biopsy of both lacrimal glands was

performed.

Results: USG, CT and NMR scans revealed the intraocular inflammation and inflammatory enlargement of both lacrimal glands.

The histopathological examination of lacrimal glands showed the presence of lymphocytic infiltrations within the glands’ tissue.

The patient started with chemotherapy: Fludarabin and Cyclophosphamide. Within weeks the intraocular inflammation was under control and the resolution of lacrimal glands edema was noted.

Conclusions: Malignancy should be considered in cases of chronic uveitis that do not respond to steroid therapy. Chronic lymphocytic leukemia rarely masks as chronic intraocular inflammation, in a sporadic cases however it may herald the relapse of

the disease.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.